Osimertinib is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Osimertinib is used to treat a certain type of non-small cell lung cancer. Osimertinib is used only if your tumor has a specific genetic marker, for which your doctor will test.
Osimertinib is usually given after other cancer medicines have been tried without success.
Osimertinib was approved by the US Food and Drug Administration (FDA) on an “accelerated” basis. In clinical studies, tumors responded to this medicine. However, further studies are needed to determine if this medicine can lengthen survival time.
Showing all 2 results
OSIM-40 Osimertinib is kinase inhibitor of the epidermal growth factor receptor (EGFR).
OSIM-80 (Osimertinib)/ Azd9291 is kinase inhibitor of the epidermal growth factor receptor (EGFR).